Exact Sciences honored as 2016 BIG Award Company of the Year in Health Care

Exact Sciences honored as 2016 BIG Award Company of the Year in Health Care

exact_big_awardsExact Sciences Corp. (Nasdaq: EXAS) today announced that the company received the Business Intelligence Group’s 2016 Company of the Year BIG Award for Business in the Health Care category.

The BIG Awards were launched in 2012 to recognize and reward companies, products and people that are leading their respective industries, as judged by business executives.

“We are honored to receive this year’s BIG Award, which recognizes the tireless efforts of our entire team to develop Cologuard and position it to become a standard of care in colon cancer screening,” said Kevin Conroy, chairman and CEO of Exact Sciences. “Since inception, we have focused on a single goal: helping win the war on cancer through early detection. Cologuard represents an important step toward reaching that goal. Thank you to the judges and the Business Intelligence Group for this recognition and congratulations to our fellow recipients for their achievements.”

In 2014, following nearly 20 years of research and development, Exact Sciences launched Cologuard®, the first and only FDA-approved, stool DNA-based screening test for adults 50 and older who are at average risk for colorectal cancer. Colon cancer is considered one of the most preventable cancers because of the extended period of time for precancer to develop into cancer. However, it’s also considered one of the least prevented cancers because more than 41 percent of Americans ages 50-75 are unscreened. Since FDA approval of Cologuard, Exact Sciences remains focused on increasing the colon cancer screening population by expanding patient access to this innovative test.

“The Business Intelligence Group highlights those with vision, creativity and persistence, all hallmarks found in the world’s leading companies and individuals across the globe,” said Russ Fordyce, managing director of the Business Intelligence Group. “Exact Sciences—in its journey to bring to market, drive awareness of and expand access to a game changer in colon cancer screening—exemplifies all of these qualities. We congratulate Exact Sciences and all of this year’s winners, as they are truly a select group.”

– Reposted from Exact Sciences